List of Moderna Therapeutics patents

Patents where

Current Assignee

Name

Moderna Therapeutics

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8710200 Engineered nucleic acids encoding a modified erythropoietin and their expression	Patent 8710200 was granted and assigned to Moderna Therapeutics on April, 2014 by the United States Patent and Trademark Office.		Moderna Therapeutics	United States Patent and Trademark Office	8710200	April 29, 2014
‌ US Patent 8999380 Modified polynucleotides for the production of biologics and proteins associated with human disease	Patent 8999380 was granted and assigned to Moderna Therapeutics on April, 2015 by the United States Patent and Trademark Office.	Moderna Therapeutics	Moderna Therapeutics	United States Patent and Trademark Office	8999380	April 7, 2015
‌ US Patent 9464124 Engineered nucleic acids and methods of use thereof	Patent 9464124 was granted and assigned to Moderna Therapeutics on October, 2016 by the United States Patent and Trademark Office.	Moderna Therapeutics	Moderna Therapeutics	United States Patent and Trademark Office	9464124	October 11, 2016
‌ US Patent 8822663 Engineered nucleic acids and methods of use thereof	Patent 8822663 was granted and assigned to Moderna Therapeutics on September, 2014 by the United States Patent and Trademark Office.		Moderna Therapeutics	United States Patent and Trademark Office	8822663	September 2, 2014
‌ US Patent 9303079 Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins	Patent 9303079 was granted and assigned to Moderna Therapeutics on April, 2016 by the United States Patent and Trademark Office.	Moderna Therapeutics	Moderna Therapeutics	United States Patent and Trademark Office	9303079	April 5, 2016
‌ US Patent 8680069 Modified polynucleotides for the production of G-CSF	Patent 8680069 was granted and assigned to Moderna Therapeutics on March, 2014 by the United States Patent and Trademark Office.	Moderna Therapeutics	Moderna Therapeutics	United States Patent and Trademark Office	8680069	March 25, 2014
‌ US Patent 9295689 Formulation and delivery of PLGA microspheres	Patent 9295689 was granted and assigned to Moderna Therapeutics on March, 2016 by the United States Patent and Trademark Office.	Moderna Therapeutics	Moderna Therapeutics	United States Patent and Trademark Office	9295689	March 29, 2016
‌ US Patent 9186372 Split dose administration	Patent 9186372 was granted and assigned to Moderna Therapeutics on November, 2015 by the United States Patent and Trademark Office.	Moderna Therapeutics	Moderna Therapeutics	United States Patent and Trademark Office	9186372	November 17, 2015
‌ US Patent 8664194 Method for producing a protein of interest in a primate	Patent 8664194 was granted and assigned to Moderna Therapeutics on March, 2014 by the United States Patent and Trademark Office.	Moderna Therapeutics	Moderna Therapeutics	United States Patent and Trademark Office	8664194	March 4, 2014
‌ US Patent 9061059 Modified polynucleotides for treating protein deficiency	Patent 9061059 was granted and assigned to Moderna Therapeutics on June, 2015 by the United States Patent and Trademark Office.	Moderna Therapeutics	Moderna Therapeutics	United States Patent and Trademark Office	9061059	June 23, 2015
‌ US Patent 9428535 Modified nucleosides, nucleotides, and nucleic acids, and uses thereof	Patent 9428535 was granted and assigned to Moderna Therapeutics on August, 2016 by the United States Patent and Trademark Office.	Moderna Therapeutics	Moderna Therapeutics	United States Patent and Trademark Office	9428535	August 30, 2016
‌ US Patent 9181319 Engineered nucleic acids and methods of use thereof	Patent 9181319 was granted and assigned to Moderna Therapeutics on November, 2015 by the United States Patent and Trademark Office.	Moderna Therapeutics	Moderna Therapeutics	United States Patent and Trademark Office	9181319	November 10, 2015
‌ US Patent 8980864 Compositions and methods of altering cholesterol levels	Patent 8980864 was granted and assigned to Moderna Therapeutics on March, 2015 by the United States Patent and Trademark Office.	Moderna Therapeutics	Moderna Therapeutics	United States Patent and Trademark Office	8980864	March 17, 2015
‌ US Patent 9283287 Modified polynucleotides for the production of nuclear proteins	Patent 9283287 was granted and assigned to Moderna Therapeutics on March, 2016 by the United States Patent and Trademark Office.	Moderna Therapeutics	Moderna Therapeutics	United States Patent and Trademark Office	9283287	March 15, 2016
‌ US Patent 9221891 In vivo production of proteins	Patent 9221891 was granted and assigned to Moderna Therapeutics on December, 2015 by the United States Patent and Trademark Office.	Moderna Therapeutics	Moderna Therapeutics	United States Patent and Trademark Office	9221891	December 29, 2015
‌ US Patent 9107886 Modified polynucleotides encoding basic helix-loop-helix family member E41	Patent 9107886 was granted and assigned to Moderna Therapeutics on August, 2015 by the United States Patent and Trademark Office.	Moderna Therapeutics	Moderna Therapeutics	United States Patent and Trademark Office	9107886	August 18, 2015
‌ US Patent 9220755 Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders	Patent 9220755 was granted and assigned to Moderna Therapeutics on December, 2015 by the United States Patent and Trademark Office.	Moderna Therapeutics	Moderna Therapeutics	United States Patent and Trademark Office	9220755	December 29, 2015
‌ US Patent 9254311 Modified polynucleotides for the production of proteins	Patent 9254311 was granted and assigned to Moderna Therapeutics on February, 2016 by the United States Patent and Trademark Office.	Moderna Therapeutics	Moderna Therapeutics	United States Patent and Trademark Office	9254311	February 9, 2016
‌ US Patent 9114113 Modified polynucleotides encoding citeD4	Patent 9114113 was granted and assigned to Moderna Therapeutics on August, 2015 by the United States Patent and Trademark Office.	Moderna Therapeutics	Moderna Therapeutics	United States Patent and Trademark Office	9114113	August 25, 2015
‌ US Patent 8754062 DLIN-KC2-DMA lipid nanoparticle delivery of modified polynucleotides	Patent 8754062 was granted and assigned to Moderna Therapeutics on June, 2014 by the United States Patent and Trademark Office.	Moderna Therapeutics	Moderna Therapeutics	United States Patent and Trademark Office	8754062	June 17, 2014
‌ US Patent 9095552 Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1	Patent 9095552 was granted and assigned to Moderna Therapeutics on August, 2015 by the United States Patent and Trademark Office.	Moderna Therapeutics	Moderna Therapeutics	United States Patent and Trademark Office	9095552	August 4, 2015
‌ US Patent 9675668 Modified polynucleotides encoding hepatitis A virus cellular receptor 2	Patent 9675668 was granted and assigned to Moderna Therapeutics on June, 2017 by the United States Patent and Trademark Office.	Moderna Therapeutics	Moderna Therapeutics	United States Patent and Trademark Office	9675668	June 13, 2017
‌ US Patent 9233141 Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders	Patent 9233141 was granted and assigned to Moderna Therapeutics on January, 2016 by the United States Patent and Trademark Office.	Moderna Therapeutics	Moderna Therapeutics	United States Patent and Trademark Office	9233141	January 12, 2016
‌ US Patent 9220792 Modified polynucleotides encoding aquaporin-5	Patent 9220792 was granted and assigned to Moderna Therapeutics on December, 2015 by the United States Patent and Trademark Office.	Moderna Therapeutics	Moderna Therapeutics	United States Patent and Trademark Office	9220792	December 29, 2015
‌ US Patent 9334328 Modified nucleosides, nucleotides, and nucleic acids, and uses thereof	Patent 9334328 was granted and assigned to Moderna Therapeutics on May, 2016 by the United States Patent and Trademark Office.	Moderna Therapeutics	Moderna Therapeutics	United States Patent and Trademark Office	9334328	May 10, 2016

Results per page:

34 results

0 selected

34 results

0 selected